Author
Listed:
- Grigory Ryzhakov
(University of Oxford)
- Nathaniel R. West
(University of Oxford
Genentech, Department of Cancer Immunology)
- Fanny Franchini
(University of Oxford)
- Simon Clare
(Wellcome Trust Sanger Institute, Hinxton)
- Nicholas E. Ilott
(University of Oxford)
- Stephen N. Sansom
(University of Oxford)
- Samuel J. Bullers
(University of Oxford)
- Claire Pearson
(University of Oxford)
- Alice Costain
(University of Oxford)
- Alun Vaughan-Jackson
(University of Oxford)
- Jeremy A. Goettel
(Boston Children’s Hospital and Harvard Medical School)
- Joerg Ermann
(Brigham and Women’s Hospital and Harvard Medical School)
- Bruce H. Horwitz
(Brigham and Women’s Hospital and Harvard Medical School)
- Ludovico Buti
(University of Oxford)
- Xin Lu
(University of Oxford)
- Subhankar Mukhopadhyay
(Wellcome Trust Sanger Institute, Hinxton)
- Scott B. Snapper
(Boston Children’s Hospital and Harvard Medical School)
- Fiona Powrie
(University of Oxford)
Abstract
Inflammatory bowel disease (IBD) are heterogenous disorders of the gastrointestinal tract caused by a spectrum of genetic and environmental factors. In mice, overlapping regions of chromosome 3 have been associated with susceptibility to IBD-like pathology, including a locus called Hiccs. However, the specific gene that controls disease susceptibility remains unknown. Here we identify a Hiccs locus gene, Alpk1 (encoding alpha kinase 1), as a potent regulator of intestinal inflammation. In response to infection with the commensal pathobiont Helicobacter hepaticus (Hh), Alpk1-deficient mice display exacerbated interleukin (IL)-12/IL-23 dependent colitis characterized by an enhanced Th1/interferon(IFN)-γ response. Alpk1 controls intestinal immunity via the hematopoietic system and is highly expressed by mononuclear phagocytes. In response to Hh, Alpk1−/− macrophages produce abnormally high amounts of IL-12, but not IL-23. This study demonstrates that Alpk1 promotes intestinal homoeostasis by regulating the balance of type 1/type 17 immunity following microbial challenge.
Suggested Citation
Grigory Ryzhakov & Nathaniel R. West & Fanny Franchini & Simon Clare & Nicholas E. Ilott & Stephen N. Sansom & Samuel J. Bullers & Claire Pearson & Alice Costain & Alun Vaughan-Jackson & Jeremy A. Goe, 2018.
"Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis,"
Nature Communications, Nature, vol. 9(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06085-5
DOI: 10.1038/s41467-018-06085-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06085-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.